Bupropion hydrochloride and Atrial fibrillation for Women aged 40-49 (a phase IV clinical study of FDA data)
Summary:
Atrial fibrillation is found for women aged 40-49 who take Bupropion hydrochloride (bupropion hydrochloride). This study is created by eHealthMe based on reports of 1,325 women aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Bupropion hydrochloride when people have Atrial fibrillation
- Top conditions
- Top co-used drugs
- Top other side effects
1,325 women aged 40-49 reported to have side effects when taking Bupropion hydrochloride.
Among them, 13 people (0.98%) have Atrial fibrillation
What is Bupropion hydrochloride?
Bupropion hydrochloride has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 21,491 Bupropion hydrochloride users. Check the latest studies of Bupropion hydrochloride.
What is Atrial fibrillation?
Atrial fibrillation (fibrillation of the muscles of the atria of the heart) is found to be associated with 2,866 drugs and 3,857 conditions by eHealthMe. Check the latest studies of Atrial fibrillation.
Number of reports submitted per year:

Time on Bupropion hydrochloride when people have Atrial fibrillation *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Atrial fibrillation
n/aHow people recovered from Atrial fibrillation
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Bipolar Disorder (mood disorder): 4 people, 30.77%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 23.08%
- Fever: 3 people, 23.08%
- Asthma: 3 people, 23.08%
- Oropharyngeal Pain: 1 person, 7.69%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 7.69%
- Ill-Defined Disorder: 1 person, 7.69%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 7.69%
- Ear Pain: 1 person, 7.69%
- Dyspnea (difficult or laboured breathing): 1 person, 7.69%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Clonazepam: 11 people, 84.62%
- Metoprolol Tartrate: 7 people, 53.85%
- Omeprazole: 7 people, 53.85%
- Fluticasone Propionate: 7 people, 53.85%
- Azithromycin: 5 people, 38.46%
- Gabapentin: 5 people, 38.46%
- Albuterol Sulfate: 4 people, 30.77%
- Lithium Carbonate: 4 people, 30.77%
- Metoprolol Succinate: 4 people, 30.77%
- Levothyroxine Sodium: 4 people, 30.77%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Asthma: 10 people, 76.92%
- Diarrhea: 9 people, 69.23%
- Nausea (feeling of having an urge to vomit): 7 people, 53.85%
- Allergic Rhinitis: 7 people, 53.85%
- Fatigue (feeling of tiredness): 7 people, 53.85%
- Irritable Bowel Syndrome: 6 people, 46.15%
- Hypersensitivity: 6 people, 46.15%
- Rashes (redness): 6 people, 46.15%
- Chest Pain: 6 people, 46.15%
- Dyspnea (difficult or laboured breathing): 6 people, 46.15%
* Approximation only. Some reports may have incomplete information.
Do you take Bupropion hydrochloride and have Atrial fibrillation?
- Check whether Atrial fibrillation is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Bolognesi M, Bolognesi D, "Medicine Ciprofloxacin-induced paroxysmal atrial fibrillation", , 2014 Mar .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
- Bolognesi M, Bolognesi D, "Ciprofloxacin-induced paroxysmal atrial fibrilation", OA Case Reports, 2012 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Bolognesi M, Bolognesi D, "Medicine Ciprofloxacin-induced paroxysmal atrial fibrillation", , 2014 Mar .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
- Bolognesi M, Bolognesi D, "Ciprofloxacin-induced paroxysmal atrial fibrilation", OA Case Reports, 2012 Jan .
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, bupropion hydrochloride (the active ingredients of Bupropion hydrochloride) and Bupropion hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cipro and Arrhythmia for Men aged 40-49 - 4 seconds ago
- Drug interactions of Evoxac and Motrin - 5 seconds ago
- Cipro and Tachycardia for Men aged 40-49 - 5 seconds ago
- Cipro and Dysrhythmias for Men aged 40-49 - 5 seconds ago
- Cipro and Abnormal Heart Rhythms for Men aged 40-49 - 5 seconds ago
- Cipro and Arrhythmias for Men aged 40-49 - 6 seconds ago
- Vitamin D and Fast Heart Rate for Men aged 40-49 - 9 seconds ago
- Vitamin D and Rapid Heart Beat for Men aged 40-49 - 9 seconds ago
- Vitamin D and Heart Rate Increased for Men aged 40-49 - 9 seconds ago
- Actos and General Ill Feeling for Women aged 30-39 - 10 seconds ago